About Us

About Us

Pediatric Infectious Diseases

 

Video: DNA Fingerprinting

The Division of Pediatric Infectious Diseases is very active in academics and research.  Faculty members are nationally recognized in their field and have a variety of interests, including vaccine development, policy, implementation, and education; outcomes research in clinical infectious diseases; hospital infection control and epidemiology; antimicrobial stewardship; and health services research.

The division has an accredited fellowship training program, a fully-equipped and staffed research laboratory, and a dedicated Pediatric Clinical Trials Unit that conducts industry-sponsored clinical trials. The division is also closely related with the Child and Adolescent Health Research Design and Support Unit.

The division has productive collaborations with the Clinical Microbiology Laboratory of the Norton Healthcare system, the Kosair Children's Hospital pharmacy, and the Kosair Charities Pediatric Clinical Research Unit.

We provide inpatient and outpatient consultation and management services for children with unusual, complicated, or recurrent infections.  Outpatient office hours are held daily at the University of Louisville Physicians-Pediatric Infectious Diseases office; all visits are by appointment only and referral by a primary care physician is required.  Urgent outpatient consultation outside of office hours can be arranged at the request of the referring physician.  A special clinic is held twice a month for children with primary immunodeficiencies, in collaboration with clinical and laboratory immunology faculty.


Clinical and Academic Fast Facts
2012 Totals
New inpatients635
Follow-up visits- inpatient
1784
New outpatients
300
Follow-up visits- outpatient    
590
Peer-reviewed publications containing original data       
18
Other publications                      
29
Abstract presentations                   
21
Invited national lectures                  

13

New industry contracts                 
$240,791
Contracts closed in 2012                 
$260,398
Ongoing contracts initiated before 2012         
$1,301,360
Other funding                        
$260,000